首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.
【2h】

Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.

机译:在实验性内毒素血症模型中,内源性调理过的颗粒将类前列腺素的作用从致死作用转变为保护作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report that, in rats, the lethal consequences of high-dose endotoxin challenge are exacerbated by the intravascular administration of prostaglandin E1 but attenuated by the intravascular administration of endocytosable particles. This protection is mediated by opsonins. Nonopsonizable particles were unable to provide protection unless first pseudoopsonized with antibody directed against the CR3 (CD11b/CD18) phagocyte receptor. We show that endogenously opsonized particles can act in concert with prostaglandin E1 (putatively by elevation of neutrophil intracellular cAMP and the resultant downregulation of CR3) to completely rescue animals from the lethal late-stage sequelae of experimental endotoxemia. These data illustrate that the interaction of particles with cellular receptors can transform the overall systemic response to prostaglandin E1 from pro- to antiinflammatory. This suggests a role for multiple receptor engagement events in defining the systemic prostaglandin response and offers a rationale for developing new therapeutic modalities in the treatment of sepsis and other inflammatory diseases.
机译:我们报告,在大鼠中,高剂量内毒素挑战的致死性后果通过前列腺素E1的血管内给药而加剧,但通过血管内可吞噬颗粒的给药而减弱。这种保护作用是由调理素介导的。除非首先用针对CR3(CD11b / CD18)吞噬细胞受体的抗体进行假调理,否则不可调理的颗粒无法提供保护。我们显示,内源性调理素颗粒可以与前列腺素E1协同作用(可能是由于嗜中性粒细胞胞内cAMP的升高和由此引起的CR3的下调),以完全从实验性内毒素血症的致命性后遗症中拯救出动物。这些数据表明,颗粒与细胞受体的相互作用可以将对前列腺素E1的整体系统反应从促炎转变为消炎。这暗示了多种受体参与事件在定义全身前列腺素反应中的作用,并为开发败血症和其他炎性疾病的治疗新方法提供了依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号